Analysis of the EAP, page-14

Welcome @LeftYahoo

I’ll keep it simple for those that are confused

Most COVID-19 deaths occur due to a cytokine storm — a process whereby the body’s own immune response runs wild causing acute and often fatal inflammation.

Vaccines are attempting to stop the storm from occurring. That’s easier said than done especially when mutations are involved.

Mesoblast role is to treat moderate/sever cases in ICU who have cytokine storm episodes developed ARDS and progressed to ventilators and have failed other treatments.

Two injections of remestemcel-L five days apart to dampen the immune system with the aim to ;

1. Keep the patient alive (survival)
2. Get the patient off ventilators
3. Reduce Hospitalization time and get the patient home with quality of life.

Early results indicate huge promise for increasing survival, ventilator dependence and reduced hospitalization.

Bottom line cytokine storms and aggressive inflammation aren’t just caused by COVID and this is where Mesoblast has a niche with ARDS.